Silver Book Fact

Imatinib, the first chemical agent to target a cancer-specific protein, improved 5-year survival rates for chromosome-positive chronic myelogenous leukemia (CML) from 17% in the mid-1970s to 63% in 2007.

SEER Stat Fact Sheets: Chronic myeloid leukemia (CML). http://seer.cancer.gov/statfacts/html/cmyl.html. Accessed November 5, 2015

American Association for Cancer Research. AACR Cancer Progress Report 2015: Transforming lives through precision medicine. Clin Cancer Res. 2015; 21(S1). http://cancerprogressreport.org/Pages/default.aspx

Reference

Title
SEER Stat Fact Sheets: Chronic myeloid leukemia (CML)
Authors
Surveillance, Epidemiology, and End Results Program (SEER)
URL
Read Full Resource
Title
AACR Cancer Progress Report 2015: Transforming lives through precision medicine
Publication
Clin Cancer Res
Publication Date
2015
Authors
American Association for Cancer Research
Volume & Issue
Volume 21, Issue S1
Pages
S1-128
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Investments in research since the 1970s have generated $1.9 trillion of value to society overall.  
  • Use of the Pap smear test is credited with cutting the age-adjusted cervical cancer incidence in half between 1975 and 2001, reducing it from 14.8 to 7.9 cases per 100,000…  
  • Imatinib, the first chemical agent to target a cancer-specific protein, improved 5-year survival rates for chromosome-positive chronic myelogenous leukemia (CML) from 17% in the mid-1970s to 63% in 2007.  
  • The 5-year survival rate for all cancers diagnosed between 1995 and 2001 is up from 50% in 1974-1976 to 65%.